BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38225399)

  • 1. An improved workflow for the development of MS-compatible liquid chromatography assay purity and purification methods by using automated LC Screening instrumentation and in silico modeling.
    Manheim J; Singh AN; Aggarwal P; Aldine FN; Haidar Ahmad IA
    Anal Bioanal Chem; 2024 Feb; 416(5):1269-1279. PubMed ID: 38225399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated ion exchange chromatography screening combined with in silico multifactorial simulation for efficient method development and purification of biopharmaceutical targets.
    Losacco GL; Hicks MB; DaSilva JO; Wang H; Potapenko M; Tsay FR; Ahmad IAH; Mangion I; Guillarme D; Regalado EL
    Anal Bioanal Chem; 2022 May; 414(12):3581-3591. PubMed ID: 35441858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing online multicolumn two-dimensional liquid chromatography screening for facile selection of stationary and mobile phase conditions in both dimensions.
    Wang H; Lhotka HR; Bennett R; Potapenko M; Pickens CJ; Mann BF; Haidar Ahmad IA; Regalado EL
    J Chromatogr A; 2020 Jul; 1622():460895. PubMed ID: 32408991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography methods using two-dimensional liquid chromatography coupled to mass spectrometry. Part I: Selection of columns and mobile phases.
    Petersson P; Buckenmaier S; Euerby MR; Stoll DR
    J Chromatogr A; 2023 Mar; 1693():463874. PubMed ID: 36841023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-column ultra-high performance liquid chromatography screening with chaotropic agents and computer-assisted separation modeling enables process development of new drug substances.
    Haidar Ahmad IA; Chen W; Halsey HM; Klapars A; Limanto J; Pirrone GF; Nowak T; Bennett R; Hartman R; Makarov AA; Mangion I; Regalado EL
    Analyst; 2019 Apr; 144(9):2872-2880. PubMed ID: 30830135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselective UHPLC Screening Combined with
    Losacco GL; Wang H; Haidar Ahmad IA; DaSilva J; Makarov AA; Mangion I; Gasparrini F; Lämmerhofer M; Armstrong DW; Regalado EL
    Anal Chem; 2022 Jan; 94(3):1804-1812. PubMed ID: 34931812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical workflow for rapid screening and purification of bioactives from venom proteomes.
    Otvos RA; Heus F; Vonk FJ; Halff J; Bruyneel B; Paliukhovich I; Smit AB; Niessen WM; Kool J
    Toxicon; 2013 Dec; 76():270-81. PubMed ID: 24140918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive online multicolumn two-dimensional liquid chromatography-diode array detection-mass spectrometry workflow as a framework for chromatographic screening and analysis of new drug substances.
    Pickens CJ; Haidar Ahmad IA; Makarov AA; Bennett R; Mann BF; Regalado EL
    Anal Bioanal Chem; 2020 Apr; 412(11):2655-2663. PubMed ID: 32128644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated Hydrophobic Interaction Chromatography Screening Combined with
    Barrientos RC; Losacco GL; Azizi M; Wang H; Nguyen AN; Shchurik V; Singh A; Richardson D; Mangion I; Guillarme D; Regalado EL; Haidar Ahmad IA
    Anal Chem; 2022 Dec; 94(49):17131-17141. PubMed ID: 36441925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Solid Phase Extraction (SPE) LC/NMR Applied to the Structural Analysis of Extractable Compounds from a Pharmaceutical Packaging Material of Construction.
    Norwood DL; Mullis JO; Davis M; Pennino S; Egert T; Gonnella NC
    PDA J Pharm Sci Technol; 2013; 67(3):267-87. PubMed ID: 23752753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilaboratory Collaborative Study of a Nontarget Data Acquisition for Target Analysis (nDATA) Workflow Using Liquid Chromatography-High-Resolution Accurate Mass Spectrometry for Pesticide Screening in Fruits and Vegetables.
    Wong JW; Wang J; Chang JS; Chow W; Carlson R; Rajski Ł; Fernández-Alba AR; Self R; Cooke WK; Lock CM; Mercer GE; Mastovska K; Schmitz J; Vaclavik L; Li L; Panawennage D; Pang GF; Zhou H; Miao S; Ho C; Lam TC; To YS; Zomer P; Hung YC; Lin SW; Liao CD; Culberson D; Taylor T; Wu Y; Yu D; Lim PL; Wu Q; Schirlé-Keller JX; Williams SM; Johnson YS; Nason SL; Ammirata M; Eitzer BD; Willis M; Wyatt S; Kwon S; Udawatte N; Priyasantha K; Wan P; Filigenzi MS; Bakota EL; Sumarah MW; Renaud JB; Parinet J; Biré R; Hort V; Prakash S; Conway M; Pyke JS; Yang DD; Jia W; Zhang K; Hayward DG
    J Agric Food Chem; 2021 Nov; 69(44):13200-13216. PubMed ID: 34709825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.
    Marinova M; Artusi C; Brugnolo L; Antonelli G; Zaninotto M; Plebani M
    Clin Biochem; 2013 Nov; 46(16-17):1723-7. PubMed ID: 24012696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Chemical Characterization Workflow for Nontargeted Analysis of Complex Extracts from Polymer Based Medical Device Using High Resolution LC/MS.
    Yu H; Kiley K; Kullar S; Fu K; Tran TN; Wang H; Hu J; Kamberi M
    ACS Biomater Sci Eng; 2023 May; 9(5):2277-2291. PubMed ID: 37094361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Multidimensional Liquid Chromatography Workflow with In-Loop Enzymatic Digests of Multiple Heart-Cuts for Fast and Flexible Characterization of Biotherapeutic Protein Variants.
    Mayr K; Weindl T; Gärtner A; Camperi J; Maetzke T; Förster M; Nachtigall T; Steiner F; Vogt A; Hosp F; Mølhøj M
    Anal Chem; 2023 Feb; 95(7):3629-3637. PubMed ID: 36745752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates.
    Drexler DM; Belcastro JV; Dickinson KE; Edinger KJ; Hnatyshyn SY; Josephs JL; Langish RA; McNaney CA; Santone KS; Shipkova PA; Tymiak AA; Zvyaga TA; Sanders M
    Assay Drug Dev Technol; 2007 Apr; 5(2):247-64. PubMed ID: 17477833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From proof of concept to the routine use of an automated and robust multi-dimensional liquid chromatography mass spectrometry workflow applied for the charge variant characterization of therapeutic antibodies.
    Goyon A; Dai L; Chen T; Wei B; Yang F; Andersen N; Kopf R; Leiss M; Mølhøj M; Guillarme D; Stella C
    J Chromatogr A; 2020 Mar; 1615():460740. PubMed ID: 31796250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography methods using two-dimensional liquid chromatography coupled to mass spectrometry. Part II: Development of second-dimension gradient conditions.
    Stoll DR; Sylvester M; Euerby MR; Buckenmaier SMC; Petersson P
    J Chromatogr A; 2023 Mar; 1693():463873. PubMed ID: 36871316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the Separation Landscape in Two-Dimensional Liquid Chromatography: Blueprints for Efficient Analysis and Purification of Pharmaceuticals Enabled by Computer-Assisted Modeling.
    Makey DM; Shchurik V; Wang H; Lhotka HR; Stoll DR; Vazhentsev A; Mangion I; Regalado EL; Ahmad IAH
    Anal Chem; 2021 Jan; 93(2):964-972. PubMed ID: 33301312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
    Huang Y; Molden R; Hu M; Qiu H; Li N
    J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.